Zhaoke Ophthalmology Limited (HKG:6622)
Hong Kong
· Delayed Price · Currency is HKD 3.430
+0.040 (1.18%)
At close: Mar 10, 2026
Zhaoke Ophthalmology Market Cap
Zhaoke Ophthalmology has a market cap or net worth of 1.86 billion as of March 10, 2026. Its market cap has increased by 91.36% in one year.
Market Cap
1.86B
Enterprise Value
1.00B
Revenue
38.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.43
Market Cap Chart
Since April 29, 2021, Zhaoke Ophthalmology's market cap has decreased from 7.66B to 1.86B, a decrease of -75.73%. That is a compound annual growth rate of -25.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 1.86B | 14.69% |
| Dec 31, 2025 | 1.62B | 147.49% |
| Dec 31, 2024 | 655.37M | -69.49% |
| Dec 29, 2023 | 2.15B | 30.79% |
| Dec 30, 2022 | 1.64B | -46.83% |
| Dec 31, 2021 | 3.09B | -59.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.98B |
| Cutia Therapeutics | 1.71B |
| Mabpharm | 1.69B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 2.07B |
| Frontage Holdings | 2.23B |
| Immunotech Biopharm | 1.45B |
| Kintor Pharmaceutical | 1.44B |
| Clover Biopharmaceuticals | 2.51B |